MedPath

Comparison of Trifecta Analysis of Standard Versus Mini Percutaneous Nephrolithotomy in the Management of Urolithiasis

Not Applicable
Completed
Conditions
Renal Stones
Urolithiasis, Calcium Oxalate
Registration Number
NCT06836700
Lead Sponsor
Hayat Abad Medical Complex, Peshawar.
Brief Summary

Introduction: Urolithiasis is a common urological condition, and percutaneous nephrolithotomy (PCNL) is a widely used treatment option. Trifecta analysis, which includes stone-free rate, reduced complications (Clavien- Dindo classification), and minimal need for auxiliary procedures, provides a standardized way to compare outcomes. This study evaluates the trifecta outcomes of standard PCNL and mini PCNL.

Detailed Description

Methodology: This prospective cohort study was conducted at the department of urology, Institute of Kidney Diseases, Peshawar from Jan 2022 to March 2024. 180 consecutive individuals who were subjected to percutaneous nephrolithotomy (PCNL) were registered for the study. Patients were randomly assigned into two equal groups using a lottery method. Both the standard PCNL group and mini PCNL group consisted of 90 patients each. Patients who required a change in the planned surgical procedure were replaced with new participants from the sample frame. A structured proforma was filled out for all preoperative, perioperative, and postoperative variables in administration of trifecta, and the data was analyzed using SPSS. An assessment was done for predictive factors for the trifecta using logistic regression to calculate the odds ratio, confidence interval (CI), and p value.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
180
Inclusion Criteria
  • Patients aged between 16 and 65 years having renal stones exceeding 20 mm in diameter or having a density more than 1000 Hounsfield Units (HU) were included.
Exclusion Criteria
  • Patients with residual stones following prior PCNL or other endourological procedures or active, untreated urinary tract infections or sepsis or patients with deranged coagulation profiles, were excluded

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Stone free ratesup to 4 weeks on post follow up imaging i.e CT KUB without contrast

This outcome measures that which modality provide better stone free rates. Mini or standard PCNL.

Post operative complications rateUp to 4 weeks days post operative period

To find which modality has got lesser number of complications. Mini or standard PCNL

Need of auxiliary ProceduresUp to 4 weeks post operatively

to find which modality require the need of auxiliary Procedures like ESWL, URS, or Re DJS stenting.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institute of Kidney Disease.

🇵🇰

Peshawar, KPK, Pakistan

© Copyright 2025. All Rights Reserved by MedPath